Real-world comparative outcomes of FOLFOX vs FOLFIRI as second-line therapy in metastatic biliary tract cancer.

Journal of Clinical Oncology 2026

View at publisher
Authors: Zunairah Shah, Sumbal Aziz, Safa Saadat Afridi, Fatima Aslam, Jayasree Krishnan, Maha Zafar, Ajinkya Buradkar, Kannan Thanikachalam
DOI: 10.1200/jco.2026.44.2_suppl.582
Cited by: 0

Abstract

582 Background: Biliary tract cancers (BTCs), including intrahepatic (IH) and extrahepatic (EH) cholangiocarcinoma and gallbladder cancer, are rare aggressive malignancies with

Fields of Study & Subjects

Cholangiocarcinoma and Gallbladder Cancer Studies Pediatric Hepatobiliary Diseases and Treatments Colorectal Cancer Treatments and Studies

Publication details

Journal / source
Journal of Clinical Oncology
Volume
44
Issue
2_suppl
Pages
582–582
Publication date
10 January 2026
Language
EN